Severe bullous erythema multiforme with atypical mucosal involvement: a rare clinical image

Pooja Kasturkar, Kavita Gomase

PAMJ. 2025; 52:118. Published 20 Nov 2025 | doi:10.11604/pamj.2025.52.118.47430

A three-year-old girl who weighed 8.4 kg and weight 80 cm tall was brought in with weakness, drowsiness, and a fever. Injection augmentin (Amoxicillin-clavulanic acid) was prescribed to her. She experienced a significant hypersensitive reaction within 24 hours, resulting in erythematous macules, bullae on the face, trunk, and extremities, and widespread involvement of the oral mucosa, which hindered oral intake. She had no known allergies, no recent pharmaceutical exposure. Laboratory investigations showed elevated erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), with a negative autoimmune panel. Serological tests confirmed mycoplasma pneumoniae infection via immunoglobulin M (IgM) positivity. Skin biopsy revealed subepidermal bullae with keratinocyte necrosis and perivascular lymphocytic infiltration, confirming bullous erythema multiforme. The case was diagnosed as severe bullous erythema multiforme with atypical mucosal involvement, resembling paediatric autoimmune blistering diseases or severe bacterial/viral stomatitis. Treatment included systemic corticosteroids (methylprednisolone 1 mg/kg/day), hydration, pain management, and supportive care. Azithromycin was started for mycoplasma pneumoniae. As her condition worsened with severe oral ulcerations and extensive blistering, intravenous immunoglobulin (IVIG) (2 g/kg) was given on day 5, leading to significant improvement within 72 hours. Supportive care included antiseptic mouthwash, petroleum jelly, oral morphine for pain, parenteral nutrition, and ophthalmologic monitoring. Dapsone (1 mg/kg/day) helped reduce new blister formation. Complete mucosal healing occurred over three weeks, allowing normal eating. At a six-month follow-up, no long-term complications were noted. The reaction was likely due to immune system immaturity, genetic predisposition, and infection-triggered hypersensitivity. This case highlights the importance of early diagnosis, prompt treatment, and multidisciplinary care in managing drug-induced severe cutaneous reactions in children.
Corresponding author
Kavita Gomase, Department of Mental Health Nursing, Smt Radhikabai Meghe Memorial College of Nursing, Datta Meghe Institute of Higher Education and Research, Sawangi (M) Wardha, India (pooja.mhn@dmiher.edu.in)

This image

  • HTML
  • PDF in process
Articles published in PAMJ are Open Access and distributed under the terms of the Creative Commons Attribution 4.0 International (CC BY 4.0).

eISSN: 1937-8688


The Pan African Medical Journal (ISSN: 1937-8688) is a subsidiary of the Pan African Medical Journal. The contents of this journal is intended exclusively for professionals in the medical, paramedical and public health and other health sectors.

Currently tracked by: DOAJ, AIM, Google Scholar, AJOL, EBSCO, Scopus, Embase, IC, HINARI, Global Health, PubMed Central, PubMed/Medline, ESCI

Physical address: "Kenya: 3rd Floor, Park Suite Building, Parkland Road, Nairobi. PoBox 38583-00100, tel: +254 (0)20-520-4356 | Cameroon: Immeuble TechnoPark Essos, Yaounde, PoBox: 10020 Yaounde, tel: +237 (0)24-309-5880"